Gilead Sciences
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
Phone: (650) 574-3000Website: https://www.gilead.com/Careers: www.gilead.com/careersPatient Assistance Program: www.gilead.com/purpose/medication-access
Latest news
- Gilead Announces Plans to Voluntarily Withdraw the U.S. Accelerated Approval for Trodelvy in Metastatic Urothelial Cancer
18 October 2024 - FDA Grants Accelerated Approval for Livdelzi (seladelpar) for the Treatment of Primary Biliary Cholangitis
14 August 2024 - Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA
6 June 2024 - Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis
5 June 2024 - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
18 May 2024 - FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV
26 April 2024 - FDA Expands Indication for Gilead's Vemlidy (tenofovir alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
28 March 2024 - U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy to Treat People with HIV with Suppressed Viral Loads, Pre-Existing Resistance
26 February 2024 - New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 Reduction and Pruritis Improvement in Primary Biliary Cholangitis in Phase 3 Post-Hoc Analysis of CymaBay's Seladelpar
3 January 2024 - FDA Approves Veklury (remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment
24 August 2023
Drugs Associated with Gilead Sciences, Inc.
Gilead Sciences, Inc. manufactures, markets and/or distributes more than 27 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
|
Atripla
Generic name: efavirenz/emtricitabine/tenofovir disoproxil Drug class: antiviral combinations |
98 reviews | 9.1 / 10 |
|
Biktarvy
Generic name: bictegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
198 reviews | 7.2 / 10 |
|
Cayston
Generic name: aztreonam Drug class: monobactams |
||
|
Complera
Generic name: emtricitabine/rilpivirine/tenofovir disoproxil Drug class: antiviral combinations |
53 reviews | 8.3 / 10 |
|
Descovy
Generic name: emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
20 reviews | 7.2 / 10 |
|
Emtriva
Generic name: emtricitabine Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
|
Epclusa
Generic name: sofosbuvir/velpatasvir Drug class: antiviral combinations |
319 reviews | 7.8 / 10 |
|
Genvoya
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
118 reviews | 7.3 / 10 |
|
Harvoni
Generic name: ledipasvir/sofosbuvir Drug class: antiviral combinations |
342 reviews | 8.6 / 10 |
|
Hepsera
Generic name: adefovir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
|
Letairis
Generic name: ambrisentan Drug class: agents for pulmonary hypertension |
11 reviews | 8.8 / 10 |
|
Livdelzi
Generic name: seladelpar Drug class: miscellaneous metabolic agents, miscellaneous uncategorized agents |
||
|
Odefsey
Generic name: emtricitabine/rilpivirine/tenofovir alafenamide Drug class: antiviral combinations |
10 reviews | 8.4 / 10 |
|
Sovaldi
Generic name: sofosbuvir Drug class: miscellaneous antivirals |
42 reviews | 7.7 / 10 |
|
Stribild
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir disoproxil Drug class: antiviral combinations |
80 reviews | 9.5 / 10 |
|
Sunlenca
Generic name: lenacapavir Drug class: miscellaneous antivirals |
2 reviews | 8.5 / 10 |
|
Tecartus
Generic name: brexucabtagene autoleucel Drug class: miscellaneous antineoplastics |
||
|
Trodelvy
Generic name: sacituzumab govitecan Drug class: miscellaneous antineoplastics |
3 reviews | 8.3 / 10 |
|
Truvada
Generic name: emtricitabine/tenofovir disoproxil Drug class: antiviral combinations |
34 reviews | 6.4 / 10 |
|
Tybost
Generic name: cobicistat Drug class: antiviral boosters |
||
|
Veklury
Generic name: remdesivir Drug class: purine nucleosides |
||
|
Vemlidy
Generic name: tenofovir alafenamide Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
1 review | 8.0 / 10 |
|
Viread
Generic name: tenofovir disoproxil Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
10 reviews | 8.0 / 10 |
|
Vosevi
Generic name: sofosbuvir/velpatasvir/voxilaprevir Drug class: antiviral combinations |
2 reviews | 10 / 10 |
|
Yescarta
Generic name: axicabtagene ciloleucel Drug class: miscellaneous antineoplastics |
||
|
Zydelig
Generic name: idelalisib Drug class: PI3K inhibitors |
2 reviews | 4.5 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Vistide
Generic name: cidofovir Drug class: purine nucleosides |
||
|
Vitekta
Generic name: elvitegravir Drug class: integrase strand transfer inhibitor |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||